Loading...
XHKG0609
Market cap128mUSD
Dec 23, Last price  
1.14HKD
1D
-1.72%
1Q
-0.87%
Jan 2017
-42.13%
IPO
79.53%
Name

Tiande Chemical Holdings Ltd

Chart & Performance

D1W1MN
XHKG:0609 chart
P/E
4.46
P/S
0.45
EPS
0.24
Div Yield, %
18.66%
Shrs. gr., 5y
0.50%
Rev. gr., 5y
12.02%
Revenues
2.08b
-40.91%
430,817,000504,187,000574,298,000725,199,000598,947,000881,775,000972,163,0001,003,895,0001,195,178,0001,121,127,0001,123,408,0001,265,389,0001,407,329,0001,179,300,0001,381,138,0001,359,393,0002,584,731,0003,520,608,0002,080,285,000
Net income
211m
-75.76%
41,711,00058,018,00021,554,00024,925,00042,044,000129,226,000132,360,000159,182,000188,086,000154,505,000172,371,000219,603,000101,562,000-61,058,00021,507,00094,821,000379,647,000870,924,000211,071,000
CFO
649m
-24.05%
61,124,0004,647,00031,591,00083,629,00047,198,000154,489,00091,288,000218,577,000174,672,000152,634,000199,392,000241,095,000277,374,00016,767,000245,150,000170,532,000274,331,000854,842,000649,233,000
Dividend
Oct 14, 20240.02 HKD/sh
Earnings
Mar 24, 2025

Profile

Tiande Chemical Holdings Limited, an investment holding company, engages in the research, development, manufacture, sale, and distribution of fine chemical products in the People's Republic of China, India, the United States, Taiwan, the United Kingdom, and internationally. Its principal products include sodium cyanide, cyanoacetic acid and cyanoacetates, malonates, diethyl ethoxymethylenemalonate, EDTA acids and salts, mono chloroacetic acid and derivatives, ethanol, tert-butanol, cyanoacrylate monomers, and related by-products. The company also engages in the research and development, manufacture, and sale of medical instrument products; and manufacture and sale of adhesive products. Its products are used in synthesis of pharmaceutical products, pesticides, adhesive products, sealants, essences, aromatics, etc. The company was founded in 1997 and is headquartered in Weifang, the People's Republic of China. Tiande Chemical Holdings Limited is a subsidiary of Cheerhill Group Limited.
IPO date
Oct 27, 2006
Employees
1,591
Domiciled in
HK
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,080,285
-40.91%
3,520,608
36.21%
2,584,731
90.14%
Cost of revenue
1,812,589
2,334,017
2,108,682
Unusual Expense (Income)
NOPBT
267,696
1,186,591
476,049
NOPBT Margin
12.87%
33.70%
18.42%
Operating Taxes
66,627
326,964
143,806
Tax Rate
24.89%
27.55%
30.21%
NOPAT
201,069
859,627
332,243
Net income
211,071
-75.76%
870,924
129.40%
379,647
300.38%
Dividends
(186,646)
(243,290)
(21,423)
Dividend yield
14.53%
12.81%
1.89%
Proceeds from repurchase of equity
18,055
BB yield
-0.95%
Debt
Debt current
45,724
154,760
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(615,063)
(1,671,508)
(1,221,646)
Cash flow
Cash from operating activities
649,233
854,842
274,331
CAPEX
(318,469)
(262,102)
(213,472)
Cash from investing activities
(543,418)
(469,451)
(84,390)
Cash from financing activities
(232,546)
(337,125)
(88,769)
FCF
197,742
529,328
138,051
Balance
Cash
615,063
492,130
226,349
Long term investments
1,225,102
1,150,057
Excess cash
511,049
1,541,202
1,247,169
Stockholders' equity
2,419,299
2,365,885
1,639,988
Invested Capital
2,046,527
937,387
556,023
ROIC
13.48%
115.12%
67.81%
ROCE
10.28%
46.97%
26.13%
EV
Common stock shares outstanding
873,606
867,510
851,954
Price
1.47
-32.88%
2.19
64.66%
1.33
104.62%
Market cap
1,284,201
-32.41%
1,899,847
67.67%
1,133,099
104.62%
EV
783,797
322,680
(80,795)
EBITDA
405,855
1,315,806
601,413
EV/EBITDA
1.93
0.25
Interest
176
2,767
6,450
Interest/NOPBT
0.07%
0.23%
1.35%